Latest News about AdvisorShares
Recent news which mentions AdvisorShares
From Benzinga
EXCLUSIVE: AdvisorShares Portfolio Manager Says Market 'Nervous' In 2025, Encourages Investors To Have 'Long-Term Focus'
March 27, 2025
From Benzinga
'Companies With Distinctive Brands Are Gaining Attention': What's Driving Cannabis Investment Today?
October 01, 2024
Tickers
CCC
From Benzinga
Waiving ETF Expense Fees: How and Why
July 01, 2024
From ETF Trends
Thematic ETF Winners of the Q1 2024 Earnings Season
May 07, 2024
From ETF Trends
Tickers
MSOS
From ETF Trends
Curious About ETFs? Learn How To Start Mastering The Market
March 27, 2024
From Benzinga
Disruptive Tech Theme of the Week: Top Thematic ETF Flows 2023
December 26, 2023
From ETF Trends
Counterpoint Debuts AI-Driven Quantitative Equity ETF
November 29, 2023
From ETF Trends
This Week in ETFs: 4 New Single-Stock Funds Debut
October 27, 2023
From ETF Trends
This Week in ETFs: Closures Outnumber New ETFs
October 13, 2023
From ETF Trends
This Week in ETFs: October Launches Start Strong
October 06, 2023
From ETF Trends
This Week in ETFs: FormulaFolios Renamed, Adds New Funds
September 29, 2023
From ETF Trends
Marijuana ETFs Rise – and Fall – on Regulatory Hopes
September 29, 2023
From ETF Trends
EXCLUSIVE: What's Next For Cannabis? Industry Experts Discuss Game-Changing New Policies
September 27, 2023
From Benzinga
From ETF Trends
Top Performing ETFs: Cannabis and Crypto Funds
May 08, 2023
From ETF Trends
NYSE’s ETF Leaders: AdvisorShares’ James Carl
May 03, 2023
From ETF Trends
From ETF Trends
From ETF Trends
AdvisorShares Expands Cannabis ETF Offerings With MSOX
August 24, 2022
From ETF Trends
From Benzinga
From ETF Trends
From ETF Trends
From ETF Trends
Cannabis ETFs Have Been Making a Quiet Comeback
February 10, 2022
From ETF Trends
AdvisorShares Launches the Poseidon Dynamic Cannabis ETF, PSDN
November 17, 2021
From ETF Trends
Interested In Investing In Cannabis? Check Out These ETFs At This Week's Benzinga Cannabis Capital Conference
October 12, 2021
From Benzinga
Travel ETFs Climb on Hopes of Merck’s Oral COVID-19 Drug
October 01, 2021
From ETF Trends
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.